HEPYX LIMITED

Active Cambridge

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
H

HEPYX LIMITED

Research and experimental development on biotechnology

Founded 8 Apr 2019 Active Cambridge, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 27 Apr 2026 Next due 30 Apr 2026 4 days overdue
Confirmation Submitted 26 Oct 2025 Next due 6 Nov 2026 6 months remaining
Net assets £-77K £35K 2024 year on year
Total assets £721K £128K 2024 year on year
Total Liabilities £798K £94K 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

Botanic House 100 Hills Road Cambridge Cambridgeshire CB2 1PH United Kingdom

Website

www.example.com

Full company profile for HEPYX LIMITED (11932437), an active company based in Cambridge, United Kingdom. Incorporated 8 Apr 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£191.89k

Increased by £82.26k (+75%)

Net Assets

-£76.86k

Decreased by £34.83k (-83%)

Total Liabilities

£797.94k

Decreased by £93.55k (-10%)

Turnover

N/A

Employees

N/A

Decreased by 2 (-100%)

Debt Ratio

111%

Increased by 6 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 17,420 Shares £61k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Mar 2021421£60k£142.5
4 Jan 20211,200£600£0.5
23 Dec 20205,800£290£0.05
23 Nov 20209,999£9.999£0.001

Officers

Officers

1 active 2 resigned
Status
Troels JordansenDirectorDanishNetherlands6120 Jun 2025Active

Shareholders

Shareholders (9)

Rajiv Jalan
57.4%
Cornellius Engelmann
8.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Professor Rajiv Jalan

Indian

Active
Notified 20 Jan 2020
Residence England
DOB December 1962
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Bobby Satyadev Yerramilli-rao

Ceased 20 Dec 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Apr 2026AccountsAnnual accounts made up to 30 Apr 2025
13 Feb 2026OfficersTermination of Julie Bailey as director on 3 Feb 2026
14 Jan 2026OfficersAppointment of Julie Bailey as director on 12 Jan 2026
26 Oct 2025Confirmation StatementConfirmation statement made on 23 Oct 2025 with no updates
22 Oct 2025Persons With Significant ControlSecond Filing Cessation Of A Person With Significant Control
27 Apr 2026 Accounts

Annual accounts made up to 30 Apr 2025

13 Feb 2026 Officers

Termination of Julie Bailey as director on 3 Feb 2026

14 Jan 2026 Officers

Appointment of Julie Bailey as director on 12 Jan 2026

26 Oct 2025 Confirmation Statement

Confirmation statement made on 23 Oct 2025 with no updates

22 Oct 2025 Persons With Significant Control

Second Filing Cessation Of A Person With Significant Control

Recent Activity

Latest Activity

Annual accounts made up to 30 Apr 2025

6 days ago on 27 Apr 2026

Termination of Julie Bailey as director on 3 Feb 2026

2 months ago on 13 Feb 2026

Appointment of Julie Bailey as director on 12 Jan 2026

3 months ago on 14 Jan 2026

Confirmation statement made on 23 Oct 2025 with no updates

6 months ago on 26 Oct 2025

Second Filing Cessation Of A Person With Significant Control

6 months ago on 22 Oct 2025